These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26625237)

  • 1. [Non-alcoholic fatty liver diseases].
    Roeb E; Steffen HM; Bojunga J
    Dtsch Med Wochenschr; 2015 Dec; 140(24):1846. PubMed ID: 26625237
    [No Abstract]   [Full Text] [Related]  

  • 2. A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver disease.
    Eng K; Lopez R; Liccardo D; Nobili V; Alkhouri N
    Dig Liver Dis; 2014 Nov; 46(11):1008-13. PubMed ID: 25106814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which patients with nonalcoholic fatty liver disease should undergo liver biopsy?
    Lindenmeyer CC; McCullough AJ
    Cleve Clin J Med; 2017 Apr; 84(4):273-275. PubMed ID: 28388384
    [No Abstract]   [Full Text] [Related]  

  • 4. [Liver diseases. Non-alcoholic fatty liver disease].
    Bernal Reyes R
    Rev Gastroenterol Mex; 2010 Aug; 75 Suppl 1():181-3. PubMed ID: 20959244
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of non-alcoholic fatty liver disease.
    Dyson J; Day C
    Dig Dis; 2014; 32(5):597-604. PubMed ID: 25034293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NONALCOHOLIC FATTY LIVER DISEASE BRAZILIAN SOCIETY OF HEPATOLOGY CONSENSUS.
    Cotrim HP; Parise ER; Figueiredo-Mendes C; Galizzi-Filho J; Porta G; Oliveira CP
    Arq Gastroenterol; 2016; 53(2):118-22. PubMed ID: 27305420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight loss outcomes after liver biopsy in patients with nonalcoholic fatty liver disease.
    You DM; Volk CG; Philo L; Partridge BJ
    Dig Liver Dis; 2014 Dec; 46(12):1136-7. PubMed ID: 25241133
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease: diagnosis and investigation.
    Nascimbeni F; Loria P; Ratziu V
    Dig Dis; 2014; 32(5):586-96. PubMed ID: 25034292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fatty liver, alcoholic steatohepatitis, and non-alcoholic steatohepatitis].
    Bernal-Reyes R
    Rev Gastroenterol Mex; 2012 Aug; 77 Suppl 1():84-6. PubMed ID: 22939493
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease in children and adolescents.
    Nobili V
    Clin Biochem; 2014 Jun; 47(9):720. PubMed ID: 24854694
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-Alcoholic Steatohepatitis: Pathogenesis and Clinical Management.
    Salomone F; Zelber-Sagi S; Galvano F; Fabbrini E
    Biomed Res Int; 2015; 2015():153276. PubMed ID: 26290862
    [No Abstract]   [Full Text] [Related]  

  • 12. Fatty liver: yet another silent killer.
    Javed M
    J Ayub Med Coll Abbottabad; 2014; 26(1):1-2. PubMed ID: 25358204
    [No Abstract]   [Full Text] [Related]  

  • 13. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.
    ; ;
    J Hepatol; 2016 Jun; 64(6):1388-402. PubMed ID: 27062661
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nonalcoholic fatty liver disease. Pathophysiologically oriented diagnosis and therapy].
    Ströhle A; Stein J
    Med Monatsschr Pharm; 2015 May; 38(5):166-78; quiz 179-80. PubMed ID: 26364406
    [No Abstract]   [Full Text] [Related]  

  • 15. [NONALCOHOLIC FATTY LIVER DISEASE: DIAGNOSTIC, SYMPTOMS, TREATMENT. GUIDELINES WERE APPROVED BY THE XV GASTROENTEROLOGICAL SCIENTIFIC SOCIETY OF RUSSIA IN 2015].
    Lazebnik LB; Radchenko VG; Golovanova EV; Zvenigorodskaya LA; Konev YV; Seliverstov PV; Sitkin SI; Tkachenko EI; Aylamazayn EK; Vlasov NN; Kornienko EA; Novikova VP; Horoshinina LP; Zhestkova NV; Oreshko LS; Dudanova OP; Dobrica VP; Turyeva LV; Tirikova OV; Kozlova NM; Eliseev SM; Gumerov RR; Vencak EV
    Eksp Klin Gastroenterol; 2015; (7):85-96. PubMed ID: 26817127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current solutions for obesity-related liver disorders: non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Raziel A; Sakran N; Szold A; Goitein D
    Isr Med Assoc J; 2015 Apr; 17(4):234-8. PubMed ID: 26040050
    [No Abstract]   [Full Text] [Related]  

  • 17. [Not Available].
    Rauh C; Dufour JF
    Ther Umsch; 2017 Jul; 74(3):87-92. PubMed ID: 28777051
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of fatty liver disease with the metabolic syndrome.
    Machado MV; Cortez-Pinto H
    Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):487-500. PubMed ID: 24665862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists.
    Mann JP; Goonetilleke R; McKiernan P
    Arch Dis Child; 2015 Jul; 100(7):673-7. PubMed ID: 25633064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NASH, from diagnosis to treatment: Where do we stand?
    Harrison SA
    Hepatology; 2015 Dec; 62(6):1652-5. PubMed ID: 26446314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.